LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 21

Search options

  1. Article ; Online: The Use of AlphaFold for

    Ros-Lucas, Albert / Martinez-Peinado, Nieves / Bastida, Jaume / Gascón, Joaquim / Alonso-Padilla, Julio

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 944748

    Abstract: Chagas disease is a devastating neglected disease caused by the ... ...

    Abstract Chagas disease is a devastating neglected disease caused by the parasite
    MeSH term(s) Animals ; Chagas Disease/drug therapy ; Chagas Disease/parasitology ; Humans ; Parasites ; Pharmaceutical Preparations ; Trypanocidal Agents/chemistry ; Trypanocidal Agents/pharmacology ; Trypanosoma cruzi
    Chemical Substances Pharmaceutical Preparations ; Trypanocidal Agents
    Language English
    Publishing date 2022-07-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.944748
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Candimine from Hippeastrum escoipense (Amaryllidaceae): Anti-Trypanosoma cruzi activity and synergistic effect with benznidazole.

    Ortiz, Javier E / Piñeiro, Mauricio / Martinez-Peinado, Nieves / Barrera, Patricia / Sosa, Miguel / Bastida, Jaume / Alonso-Padilla, Julio / Feresin, Gabriela E

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2023  Volume 114, Page(s) 154788

    Abstract: Background: Chagas disease (CD), caused by Trypanosoma cruzi, represents a health threat to around 20 million people worldwide. Side effects of benznidazole (Bzn) cause 15-20% of patients to discontinue their treatment. Evidence has increased in favor ... ...

    Abstract Background: Chagas disease (CD), caused by Trypanosoma cruzi, represents a health threat to around 20 million people worldwide. Side effects of benznidazole (Bzn) cause 15-20% of patients to discontinue their treatment. Evidence has increased in favor of the use of drug combinations to improve the efficacy and tolerance of the treatment. Natural products are well known to provide structures that could serve as new drugs or scaffolds for CD treatment. Spp of the Amaryllidoideae sub family of Amaryllidaceae family are known by their bioactives alkaloids, which have been reported by their antiparasitic activities.
    Purpose: To evaluate the anti-T. cruzi activity of the isolated alkaloid candimine (Cnd) from Hippeastrum escoipense Slanis & Huaylla; and to assess the combination effect between Cnd and Bzn against different life stages of T. cruzi parasites.
    Methods: The chemical profile of H. escoipense alkaloids extract (AE-H. escoipense), including quantitation of Cnd was performed through GC/MS and UPLC-MS/MS techniques. Subsequently, Cnd was isolated using Shephadex LH-20. Then, the AE-H. escoipense and Cnd were tested against T. cruzi, (epimastigotes, trypomastigotes, and amastigotes) by in vitro proliferation and viability assays. The cytotoxicity was evaluated against Vero and HepG2 mammalian cells. The ultrastructural analysis was perform by transmission electron microscopy (TEM) and mitochondrial activity was carried out by MTT assay. Drug combination assay between Cnd and Bzn was evaluated using the Chou-Talalay method.
    Results: The AE-H. escoipense and Cnd showed high and specific anti-T. cruzi activity, comparable to Bzn. Cnd induces ultrastructural changes in T. cruzi, such as vacuolization, membrane blebs, and increased mitochondrial activity. Regarding the interaction between Cnd and Bzn, it generates synergism in the combinations of 0.25×IC
    Conclusion: The synergism between Cnd and Bzn indicates that the combination at the concentration of 4×IC
    MeSH term(s) Animals ; Humans ; Trypanosoma cruzi ; Amaryllidaceae ; Chromatography, Liquid ; Tandem Mass Spectrometry ; Chagas Disease/drug therapy ; Alkaloids/pharmacology ; Trypanocidal Agents/pharmacology ; Mammals
    Chemical Substances benzonidazole (YC42NRJ1ZD) ; candimine ; Alkaloids ; Trypanocidal Agents
    Language English
    Publishing date 2023-03-29
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2023.154788
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Candimine from Hippeastrum escoipense (Amaryllidaceae): Anti-Trypanosoma cruzi activity and synergistic effect with benznidazole

    Ortiz, Javier E. / Piñeiro, Mauricio / Martinez-Peinado, Nieves / Barrera, Patricia / Sosa, Miguel / Bastida, Jaume / Alonso-Padilla, Julio / Feresin, Gabriela E.

    Phytomedicine. 2023 June, v. 114 p.154788-

    2023  

    Abstract: Chagas disease (CD), caused by Trypanosoma cruzi, represents a health threat to around 20 million people worldwide. Side effects of benznidazole (Bzn) cause 15–20% of patients to discontinue their treatment. Evidence has increased in favor of the use of ... ...

    Abstract Chagas disease (CD), caused by Trypanosoma cruzi, represents a health threat to around 20 million people worldwide. Side effects of benznidazole (Bzn) cause 15–20% of patients to discontinue their treatment. Evidence has increased in favor of the use of drug combinations to improve the efficacy and tolerance of the treatment. Natural products are well known to provide structures that could serve as new drugs or scaffolds for CD treatment. Spp of the Amaryllidoideae sub family of Amaryllidaceae family are known by their bioactives alkaloids, which have been reported by their antiparasitic activities. To evaluate the anti-T. cruzi activity of the isolated alkaloid candimine (Cnd) from Hippeastrum escoipense Slanis & Huaylla; and to assess the combination effect between Cnd and Bzn against different life stages of T. cruzi parasites. The chemical profile of H. escoipense alkaloids extract (AE-H. escoipense), including quantitation of Cnd was performed through GC/MS and UPLC-MS/MS techniques. Subsequently, Cnd was isolated using Shephadex LH-20. Then, the AE-H. escoipense and Cnd were tested against T. cruzi, (epimastigotes, trypomastigotes, and amastigotes) by in vitro proliferation and viability assays. The cytotoxicity was evaluated against Vero and HepG2 mammalian cells. The ultrastructural analysis was perform by transmission electron microscopy (TEM) and mitochondrial activity was carried out by MTT assay. Drug combination assay between Cnd and Bzn was evaluated using the Chou-Talalay method. The AE-H. escoipense and Cnd showed high and specific anti-T. cruzi activity, comparable to Bzn. Cnd induces ultrastructural changes in T. cruzi, such as vacuolization, membrane blebs, and increased mitochondrial activity. Regarding the interaction between Cnd and Bzn, it generates synergism in the combinations of 0.25×IC₅₀ in epimastigotes, 2×IC₅₀ in trypomastigotes+amastigotes, and 0.25, 2, and 4×IC₅₀ in amastigotes. The synergism between Cnd and Bzn indicates that the combination at the concentration of 4×IC₅₀ could be useful as an effective new therapy against CD in the chronic stage. Thus, Cnd isolated from the leaves of H. escoipense emerges as potential candidate for the development of a new drug for the treatment of CD.
    Keywords Chagas disease ; Hippeastrum ; Trypanosoma cruzi ; alkaloids ; amastigotes ; benznidazole ; bioactive compounds ; cytotoxicity ; epimastigotes ; mammals ; mitochondria ; synergism ; therapeutics ; toxicity testing ; transmission electron microscopy ; trypomastigotes ; viability ; Amaryllidaceae alkaloids ; Antiparasitic assays ; Neglected disease ; Candimine ; AA ; ACN ; AE ; Bzn ; CD ; CI ; Cnd ; DRI ; DTU ; Fa ; FBS ; IC50 ; InC ; MOI ; MTT ; n°p ; Nfx ; NMR ; PBS ; RI ; ROS ; SI ; SIR ; TC50 ; TEM
    Language English
    Dates of publication 2023-06
    Publishing place Elsevier GmbH
    Document type Article ; Online
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2023.154788
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article: An Overview of Current Uses and Future Opportunities for Computer-Assisted Design of Vaccines for Neglected Tropical Diseases.

    Robleda-Castillo, Raquel / Ros-Lucas, Albert / Martinez-Peinado, Nieves / Alonso-Padilla, Julio

    Advances and applications in bioinformatics and chemistry : AABC

    2021  Volume 14, Page(s) 25–47

    Abstract: Neglected tropical diseases are infectious diseases that impose high morbidity and mortality rates over 1.5 billion people worldwide. Originally restricted to tropical and subtropical regions, changing climate conditions have increased their potential to ...

    Abstract Neglected tropical diseases are infectious diseases that impose high morbidity and mortality rates over 1.5 billion people worldwide. Originally restricted to tropical and subtropical regions, changing climate conditions have increased their potential to emerge elsewhere. Control of their impact suffers from shortages like poor epidemiological surveillance or irregular drug distribution, and some NTDs still lack of appropriate diagnostics and/or efficient therapeutics. For these, availability of vaccines to prevent new infections, or the worsening of those already established, would mean a major breakthrough. However, only dengue and rabies count with approved vaccines at present. Herein, we review the state-of-the-art of vaccination strategies for NTDs, setting the focus on third generation vaccines and the concept of reverse vaccinology. Its capability to address pathogens´ biological complexity, likely contributing to save developmental costs is discussed. The use of computational tools is a fundamental aid to analyze increasingly large datasets aimed at designing vaccine candidates with the highest, possibly, opportunities to succeed. Ultimately, we identify and analyze those studies that took an in silico approach to find vaccine candidates, and experimentally assessed their immunogenicity and/or protection capabilities.
    Language English
    Publishing date 2021-02-15
    Publishing country New Zealand
    Document type Journal Article ; Review
    ISSN 1178-6949
    ISSN 1178-6949
    DOI 10.2147/AABC.S258759
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparum

    Fenollar, Àngel / Ros-Lucas, Albert / Pía Alberione, María / Martínez-Peinado, Nieves / Ramírez, Miriam / Ángel Rosales-Motos, Miguel / Y. Lee, Ling / Alonso-Padilla, Julio / Izquierdo, Luis

    Computational and Structural Biotechnology Journal. 2022, v. 20

    2022  

    Abstract: The emergence of resistance to first-line antimalarials, including artemisinin, the last effective malaria therapy in some regions, stresses the urgent need to develop new effective treatments against this disease. The identification and validation of ... ...

    Abstract The emergence of resistance to first-line antimalarials, including artemisinin, the last effective malaria therapy in some regions, stresses the urgent need to develop new effective treatments against this disease. The identification and validation of metabolic pathways that could be targeted for drug development may strongly contribute to accelerate this process. In this study, we use fully characterized specific inhibitors targeting glycan biosynthetic pathways as research tools to analyze their effects on the growth of the malaria parasite Plasmodium falciparum and to validate these metabolic routes as feasible chemotherapeutic targets. Through docking simulations using models predicted by AlphaFold, we also shed new light into the modes of action of some of these inhibitors. Molecules inhibiting N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (GlcNAc-PI de-N-acetylase, PIGL/GPI12) or the inositol acyltransferase (GWT1), central for glycosylphosphatidylinositol (GPI) biosynthesis, halt the growth of intraerythrocytic asexual parasites during the trophozoite stages of the intraerythrocytic developmental cycle (IDC). Remarkably, the nucleoside antibiotic tunicamycin, which targets UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosaminephosphotransferase (ALG7) and N-glycosylation in other organisms, induces a delayed-death effect and inhibits parasite growth during the second IDC after treatment. Our data indicate that tunicamycin induces a specific inhibitory effect, hinting to a more substantial role of the N-glycosylation pathway in P. falciparum intraerythrocytic asexual stages than previously thought. To sum up, our results place GPI biosynthesis and N-glycosylation pathways as metabolic routes with potential to yield much-needed therapeutic targets against the parasite.
    Keywords Plasmodium falciparum ; artemisinin ; biosynthesis ; biotechnology ; drug development ; drug therapy ; glycosylation ; inositols ; malaria ; parasites ; tunicamycin
    Language English
    Size p. 850-863.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 2694435-2
    ISSN 2001-0370
    ISSN 2001-0370
    DOI 10.1016/j.csbj.2022.01.029
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation.

    Gabaldón-Figueira, Juan Carlos / Martinez-Peinado, Nieves / Escabia, Elisa / Ros-Lucas, Albert / Chatelain, Eric / Scandale, Ivan / Gascon, Joaquim / Pinazo, María-Jesús / Alonso-Padilla, Julio

    Research and reports in tropical medicine

    2023  Volume 14, Page(s) 1–19

    Abstract: Chagas disease is the most important protozoan infection in the Americas, and constitutes a significant public health concern throughout the world. Development of new medications against its etiologic agent, ...

    Abstract Chagas disease is the most important protozoan infection in the Americas, and constitutes a significant public health concern throughout the world. Development of new medications against its etiologic agent,
    Language English
    Publishing date 2023-06-14
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2578572-2
    ISSN 1179-7282 ; 1179-7282
    ISSN (online) 1179-7282
    ISSN 1179-7282
    DOI 10.2147/RRTM.S415273
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against

    Martinez-Peinado, Nieves / Gabaldon-Figueira, Juan Carlos / Martinez-Añon, Ignacio / Rodríguez-Gordo, Cristian / Robleda-Castillo, Raquel / Pinazo, Maria-Jesus / Bigey, Pascal / Gascon, Joaquim / Alonso-Padilla, Julio

    Microorganisms

    2023  Volume 11, Issue 2

    Abstract: Mounting a balanced and robust humoral immune response is of utmost importance for reducing the infectivity ... ...

    Abstract Mounting a balanced and robust humoral immune response is of utmost importance for reducing the infectivity of
    Language English
    Publishing date 2023-01-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms11020241
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Practical diagnostic algorithms for Chagas disease: a focus on low resource settings.

    Gabaldón-Figueira, Juan Carlos / Skjefte, Malia / Longhi, Silvia / Escabia, Elisa / García, Lady Juliette / Ros-Lucas, Albert / Martínez-Peinado, Nieves / Muñoz-Calderón, Arturo / Gascón, Joaquim / Schijman, Alejandro Gabriel / Alonso-Padilla, Julio

    Expert review of anti-infective therapy

    2023  Volume 21, Issue 12, Page(s) 1287–1299

    Abstract: Introduction: Chagas disease, caused by parasite : Areas covered: This review outlines existing algorithms, and proposes new ones focused on point-of-care testing.: Expert opinion: Integrating point-of-care testing into existing diagnostic ... ...

    Abstract Introduction: Chagas disease, caused by parasite
    Areas covered: This review outlines existing algorithms, and proposes new ones focused on point-of-care testing.
    Expert opinion: Integrating point-of-care testing into existing diagnostic algorithms in certain endemic areas will increase access to timely diagnosis and treatment. However, additional research is needed to validate the use of these techniques across a wider geography, and to better understand the cost-effectiveness of their large-scale implementation.
    MeSH term(s) Humans ; Chagas Disease/diagnosis ; Chagas Disease/epidemiology ; Trypanosoma cruzi ; Point-of-Care Testing ; Rapid Diagnostic Tests ; Algorithms
    Language English
    Publishing date 2023-11-24
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2181279-2
    ISSN 1744-8336 ; 1478-7210
    ISSN (online) 1744-8336
    ISSN 1478-7210
    DOI 10.1080/14787210.2023.2279110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease.

    Martínez-Peinado, Nieves / Cortes-Serra, Nuria / Tallini, Luciana R / Pinazo, Maria-Jesus / Gascon, Joaquim / Bastida, Jaume / Alonso-Padilla, Julio

    Parasites & vectors

    2021  Volume 14, Issue 1, Page(s) 337

    Abstract: Background: Chagas disease is a neglected zoonosis caused by the parasite Trypanosoma cruzi. It affects over six million people, mostly in Latin America. Drugs available to treat T. cruzi infection have associated toxicity and questionable efficacy at ... ...

    Abstract Background: Chagas disease is a neglected zoonosis caused by the parasite Trypanosoma cruzi. It affects over six million people, mostly in Latin America. Drugs available to treat T. cruzi infection have associated toxicity and questionable efficacy at the chronic stage. Hence, the discovery of more effective and safer drugs is an unmet medical need. For this, natural products represent a pool of unique chemical diversity that can serve as excellent templates for the synthesis of active molecules.
    Methods: A collection of 79 extracts of Amaryllidaceae plants were screened against T. cruzi. Active extracts against the parasite were progressed through two cell toxicity assays based on Vero and HepG2 cells to determine their selectivity profile and discard those toxic to host cells. Anti-T. cruzi-specific extracts were further qualified by an anti-amastigote stage assay.
    Results: Two extracts, respectively from Crinum erubescens and Rhodophiala andicola, were identified as highly active and specific against T. cruzi and its mammalian replicative form.
    Conclusions: The results retrieved in this study encourage further exploration of the chemical content of these extracts in search of new anti-T. cruzi drug development starting points.
    MeSH term(s) Amaryllidaceae/chemistry ; Chagas Disease/drug therapy ; Chagas Disease/parasitology ; Drug Evaluation, Preclinical ; Humans ; Plant Extracts/pharmacology ; Trypanocidal Agents/chemistry ; Trypanocidal Agents/pharmacology ; Trypanosoma cruzi/drug effects ; Trypanosoma cruzi/physiology
    Chemical Substances Plant Extracts ; Trypanocidal Agents
    Language English
    Publishing date 2021-06-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 2409480-8
    ISSN 1756-3305 ; 1756-3305
    ISSN (online) 1756-3305
    ISSN 1756-3305
    DOI 10.1186/s13071-021-04837-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Identification of

    Martinez-Peinado, Nieves / Cortes-Serra, Nuria / Sherman, Julian / Rodriguez, Ana / Bustamante, Juan M / Gascon, Joaquim / Pinazo, Maria-Jesus / Alonso-Padilla, Julio

    Microorganisms

    2021  Volume 9, Issue 2

    Abstract: Chagas disease, caused by the ... ...

    Abstract Chagas disease, caused by the parasite
    Language English
    Publishing date 2021-02-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms9020406
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top